Copyright Reports & Markets. All rights reserved.

Global Statins Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Statins Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Statins Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Statins Market Size Growth Rate by Type
    • 1.4.2 Astrovastatin
    • 1.4.3 Fluvastatin
    • 1.4.4 Lovastatin
    • 1.4.5 Pravastatin
    • 1.4.6 Simvastatin
    • 1.4.7 Others
  • 1.5 Market by Application
    • 1.5.1 Global Statins Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Statins Market Size, Estimates and Forecasts
    • 2.1.1 Global Statins Revenue 2015-2026
    • 2.1.2 Global Statins Sales 2015-2026
  • 2.2 Global Statins, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Statins Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Statins Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Statins Competitor Landscape by Players

  • 3.1 Statins Sales by Manufacturers
    • 3.1.1 Statins Sales by Manufacturers (2015-2020)
    • 3.1.2 Statins Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Statins Revenue by Manufacturers
    • 3.2.1 Statins Revenue by Manufacturers (2015-2020)
    • 3.2.2 Statins Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Statins Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Statins Revenue in 2019
    • 3.2.5 Global Statins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Statins Price by Manufacturers
  • 3.4 Statins Manufacturing Base Distribution, Product Types
    • 3.4.1 Statins Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Statins Product Type
    • 3.4.3 Date of International Manufacturers Enter into Statins Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Statins Market Size by Type (2015-2020)
    • 4.1.1 Global Statins Sales by Type (2015-2020)
    • 4.1.2 Global Statins Revenue by Type (2015-2020)
    • 4.1.3 Statins Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Statins Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Statins Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Statins Revenue Forecast by Type (2021-2026)
    • 4.2.3 Statins Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Statins Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Statins Market Size by Application (2015-2020)
    • 5.1.1 Global Statins Sales by Application (2015-2020)
    • 5.1.2 Global Statins Revenue by Application (2015-2020)
    • 5.1.3 Statins Price by Application (2015-2020)
  • 5.2 Statins Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Statins Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Statins Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Statins Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Statins by Country
    • 6.1.1 North America Statins Sales by Country
    • 6.1.2 North America Statins Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Statins Market Facts & Figures by Type
  • 6.3 North America Statins Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Statins by Country
    • 7.1.1 Europe Statins Sales by Country
    • 7.1.2 Europe Statins Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Statins Market Facts & Figures by Type
  • 7.3 Europe Statins Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Statins by Region
    • 8.1.1 Asia Pacific Statins Sales by Region
    • 8.1.2 Asia Pacific Statins Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Statins Market Facts & Figures by Type
  • 8.3 Asia Pacific Statins Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Statins by Country
    • 9.1.1 Latin America Statins Sales by Country
    • 9.1.2 Latin America Statins Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Statins Market Facts & Figures by Type
  • 9.3 Central & South America Statins Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Statins by Country
    • 10.1.1 Middle East and Africa Statins Sales by Country
    • 10.1.2 Middle East and Africa Statins Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Statins Market Facts & Figures by Type
  • 10.3 Middle East and Africa Statins Market Facts & Figures by Application

11 Company Profiles

  • 11.1 AstraZeneca
    • 11.1.1 AstraZeneca Corporation Information
    • 11.1.2 AstraZeneca Description and Business Overview
    • 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AstraZeneca Statins Products Offered
    • 11.1.5 AstraZeneca Related Developments
  • 11.2 Pfizer
    • 11.2.1 Pfizer Corporation Information
    • 11.2.2 Pfizer Description and Business Overview
    • 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Pfizer Statins Products Offered
    • 11.2.5 Pfizer Related Developments
  • 11.3 GlaxoSmithKline
    • 11.3.1 GlaxoSmithKline Corporation Information
    • 11.3.2 GlaxoSmithKline Description and Business Overview
    • 11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 GlaxoSmithKline Statins Products Offered
    • 11.3.5 GlaxoSmithKline Related Developments
  • 11.4 Novartis International
    • 11.4.1 Novartis International Corporation Information
    • 11.4.2 Novartis International Description and Business Overview
    • 11.4.3 Novartis International Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Novartis International Statins Products Offered
    • 11.4.5 Novartis International Related Developments
  • 11.5 Merck
    • 11.5.1 Merck Corporation Information
    • 11.5.2 Merck Description and Business Overview
    • 11.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Merck Statins Products Offered
    • 11.5.5 Merck Related Developments
  • 11.6 Biocon
    • 11.6.1 Biocon Corporation Information
    • 11.6.2 Biocon Description and Business Overview
    • 11.6.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Biocon Statins Products Offered
    • 11.6.5 Biocon Related Developments
  • 11.7 Concord Biotech
    • 11.7.1 Concord Biotech Corporation Information
    • 11.7.2 Concord Biotech Description and Business Overview
    • 11.7.3 Concord Biotech Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Concord Biotech Statins Products Offered
    • 11.7.5 Concord Biotech Related Developments
  • 11.8 Aurobindo Pharma
    • 11.8.1 Aurobindo Pharma Corporation Information
    • 11.8.2 Aurobindo Pharma Description and Business Overview
    • 11.8.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Aurobindo Pharma Statins Products Offered
    • 11.8.5 Aurobindo Pharma Related Developments
  • 11.1 AstraZeneca
    • 11.1.1 AstraZeneca Corporation Information
    • 11.1.2 AstraZeneca Description and Business Overview
    • 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AstraZeneca Statins Products Offered
    • 11.1.5 AstraZeneca Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Statins Market Estimates and Projections by Region
    • 12.1.1 Global Statins Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Statins Revenue Forecast by Regions 2021-2026
  • 12.2 North America Statins Market Size Forecast (2021-2026)
    • 12.2.1 North America: Statins Sales Forecast (2021-2026)
    • 12.2.2 North America: Statins Revenue Forecast (2021-2026)
    • 12.2.3 North America: Statins Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Statins Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Statins Sales Forecast (2021-2026)
    • 12.3.2 Europe: Statins Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Statins Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Statins Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Statins Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Statins Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Statins Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Statins Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Statins Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Statins Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Statins Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Statins Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Statins Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Statins Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Statins Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Statins Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Statins Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Statins market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Statins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Statins market is segmented into
    Astrovastatin
    Fluvastatin
    Lovastatin
    Pravastatin
    Simvastatin
    Others

    Segment by Application, the Statins market is segmented into
    Hospitals
    Clinics

    Regional and Country-level Analysis
    The Statins market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Statins market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Statins Market Share Analysis
    Statins market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Statins business, the date to enter into the Statins market, Statins product introduction, recent developments, etc.

    The major vendors covered:
    AstraZeneca
    Pfizer
    GlaxoSmithKline
    Novartis International
    Merck
    Biocon
    Concord Biotech
    Aurobindo Pharma

    Buy now